Matinas BioPharma Holdings Inc (MTNB)
0.5799
+0.04
(+7.39%)
USD |
NYAM |
Nov 21, 16:00
0.5407
-0.04
(-6.76%)
Pre-Market: 09:24
Matinas BioPharma Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.0019 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.0124 |
| September 30, 2018 | 0.031 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.005 |
| December 31, 2017 | 0.0159 |
| September 30, 2017 | 0.0233 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.0025 |
| December 31, 2016 | 0.0165 |
| September 30, 2016 | 0.0217 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0014 |
| June 30, 2015 | 0.0012 |
| March 31, 2015 | 0.0016 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Equillium Inc | 0.00 |
| Tenon Medical Inc | 0.00 |
| Alphatec Holdings Inc | -387.46 |
| Merck & Co Inc | 0.8568 |
| Madrigal Pharmaceuticals Inc | 0.1507 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 20.58M |
| Total Liabilities (Quarterly) | 4.798M |
| Shareholders Equity (Quarterly) | 15.78M |